Emory University Amarin Corp Plcuk Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $1.84 Million - $3.06 Million	-132,255 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $45,604 - $57,489	-2,803 Reduced 2.08%	132,255 $2.56 Million
Q1 2019 May 09, 2019	BUY	$12.61 - $22.33 $71,435 - $126,499	5,665 Added 4.38%	135,058 $2.8 Million
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $1.61 Million - $2.97 Million	129,393 New	129,393 $1.76 Million

184

88M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $306M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.